Home ›
Trademark Categories ›
Pharmaceuticals ›
2016 ›
FI ›
FIRAZYR-PED
Trademark search for:
FIRAZYR-PED
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2016-04-01 — Application filed
2016-04-05 — Application filed
2016-04-06 — Application filed
2016-06-17 — Assigned to examiner
2016-06-21 — Notification of examiners amendment e-mailed
2016-06-21 — Examiners amendment e-mailed
2016-06-21 — Examiners amendment -written
2016-06-21 — Examiner's amendment entered
2016-06-21 — Approved for pub - principal register
2016-06-30 — Assigned to lie
2016-07-05 — Law office publication review completed
2016-07-20 — Notification of notice of publication e-mailed
2016-08-05 — Teas petition to amend basis received
2016-08-09 — Published for opposition
2016-08-09 — Official gazette publication confirmation e-mailed
2016-08-22 — Assigned to petition staff
2016-08-23 — Petition to director - change basis - granted
2016-08-23 — Attorney review/decision on amendment required
2016-08-26 — Attorney review completed
2016-09-14 — Notification of notice of publication e-mailed
2016-10-04 — Published for opposition
2016-10-04 — Official gazette publication confirmation e-mailed
2016-12-20 — Registered-principal register
2020-07-01 — Teas change of owner address received
2020-07-01 — Teas revoke/app/change addr of atty/dom rep received
2020-07-01 — Attorney/dom.rep.revoked and/or appointed
2020-07-01 — Teas change of domestic representatives address
2020-07-01 — Teas change of correspondence received
2020-07-01 — Applicant/correspondence changes (non-responsive) entered
2020-07-02 — Review of correspondence complete - address updated
2021-12-20 — Courtesy reminder - sec. 8 (6-yr) e-mailed
2023-06-30 — Cancelled sec. 8 (6-yr)
2023-06-30 — Final status recorded
Owner Information
Shire Orphan Therapies GmbH
Shire Orphan Therapies GmbH
Shire Orphan Therapies GmbH
Correspondent
Karl M. Zielaznicki, Esq. Troutman Pepper Hamilton Sanders LLP
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
